In English | En español
Questions About Cancer? 1-800-4-CANCER

Screening and Testing to Detect Cancer: Prostate Cancer

< Back to Screening and Testing Home Page

Page Options

  • Print This Page
  • Email This Document

Related Pages

Screening and Testing to Detect Prostate Cancer

Researchers are working on developing effective methods to screen for prostate cancer. However,  it has not yet been shown that screening for prostate cancer decreases the chances of dying from prostate cancer.

On this page:

Prostate Cancer Screening Summary

Prostate-Specific Antigen (PSA)

  • Prostate-Specific Antigen (PSA) Test
    A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.
  • PSA Screening Leads to Aggressive Treatment, Even in Older Men at Low Risk
    Screening for prostate cancer with the prostate-specific antigen (PSA) test has led to overtreatment of many prostate cancers, including aggressive treatments in older men considered to be at low risk for progression of the disease according to a study published in the July 26, 2010 Archives of Internal Medicine.
  • Panel Recommends Against PSA Testing in Men 75 or Older
    The U.S. Preventive Services Task Force is advising against the routine use of prostate-specific antigen (PSA) testing to screen for prostate cancer in men age 75 and older, according to guidelines published in the August 5, 2008, Annals of Internal Medicine.

Clinical Trials to Screen for Prostate Cancer

Find Clinical Trials to Screen for Prostate Cancer
Check for prostate cancer screening trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location and other features.

Research About Prostate Cancer Screening

Prostate Changes and Conditions

Back to TopBack to Top